IOM Argument to End 510(k)s Is Defended in FDLI Report

Devices & Diagnostics Letter
The FDA should establish a new standard for premarket clearance to tell the difference between products that can be approved based on predicate devices alone and those that need more rigorous postmarket approval, says one legal expert.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00